Due to its role in regulating both β-catenin and NF-κB signalling, it is interesting to speculate that BCL-3 may enhance the de-differentiation of non-stem cells (91), therefore aiding reconstitution of the tumour when the cancer stem cells have been deleted (94). The gene discussed is NFKB1; the disease is neoplasm.